Gyakorlatok daganatos betegeknek — ACSM exercise-oncology konszenzus

Exercise oncology used to be cautious — 'rest during treatment, exercise after recovery.' The ACSM 2019 exercise-oncology consensus (Campbell et al.) reversed that with a meta-analysis of 100+ trials. The headline: 150 minutes/week moderate aerobic + resistance training 2-3 times per week is safe AND beneficial during AND after treatment for most cancer + treatment combinations. The single largest effect size is on cancer-related fatigue — paradoxically, exercise reduces fatigue when most patients feel like exercise will worsen it. Mechanism is multiple: improved muscle quality (sarcopenia is universal during chemo/radiation), reduced inflammation, mood improvement, sleep architecture, and recurrence-risk reduction in hormone-driven cancers (breast and colon especially). Each cancer + treatment combination has specific considerations — bone-mets risk modifies impact loading, peripheral neuropathy modifies balance work, lymphedema risk modifies upper-body protocols.

Volya's catalogue carries the foundation moves: slow-arm-swing-walk for entry-level cardio, standing-march and seated-march for indoor or fatigue-state alternatives, wall-push-up for low-load upper-body strength, single-leg-stance for balance (chemo-induced peripheral neuropathy raises fall risk), supported-glute-bridge for joint-friendly glute work, cat-cow for gentle mobility, diaphragmatic-breathing for stress regulation, and scapular-retraction for posture. The AI coach also knows the nutrition side — Mediterranean pattern (PREDIMED data), protein 1.0-1.5 g/kg (combat treatment-related sarcopenia), small frequent meals during chemo nausea, vitamin D under oncology team guidance, supplement caution during treatment (some antioxidants interfere with chemo/radiation), alcohol avoidance during active treatment. This page is informational — work with your oncology team for every specific contraindication.